James Aloysius Brady Verona Pharma PLC (VRNA) insider trading activity

James Aloysius Brady is Director of Verona Pharma plc. Currently has a direct ownership of 23,176 shares of VRNA, which is worth approximately $2.45 Million. The most recent transaction as insider was on Aug 01, 2025, when has been sold 824 shares (Ordinary Shares) at a price of $13.14 per share, resulting in proceeds of $10,827. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 23.2K

n/a 3M change

n/a 12M change

Total Value Held $2.45 Million

James Aloysius Brady Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Aug 01 2025	SELL Open market or private sale	$10,827 $13.14 p/Share	824 Reduced 3.43%	23,176 Ordinary Shares
Aug 01 2025	BUY Exercise of conversion of derivative security	-	24,000 Added 50.0%	24,000 Ordinary Shares

Also insider at

XERS

Xeris Biopharma Holdings, Inc. Healthcare

Director

JAB